Willingness-to-pay for a hypothetical Ebola vaccine in Indonesia: A cross-sectional study in Aceh

Abstract

Background: Some Ebola vaccines have been developed and tested in phase III clinical trials. However, assessment of whether public have willingness to purchase or not, especially in unaffected areas, is lacking. The aim of this study was to determine willingness to pay (WTP) for a hypothetical Ebola vaccine in Indonesia. Methods: A cross-sectional study was conducted from 1 August to 30 December 2015 in five cities in Aceh province of Indonesia. Patients’ family members who visited outpatient departments were approached and interviewed about their sociodemographic characteristics, knowledge of Ebola, attitude towards vaccination practice and their WTP for a hypothetical Ebola vaccine. A multivariable linear regression model assessed the relationship between these explanatory variables and WTP. Results: During the study, 500 participants were approached and interviewed. There were 424 (84.8%) respondents who completed the interview and 74% (311/424) expressed their acceptance for an Ebola vaccine. There were 288 participants who were willing to pay for an Ebola vaccine (92.6% out of 311). The mean of WTP was US$2.08 (95% CI: 1.75-2.42). The final multivariable model indicated that young age, high educational attainment, working as a private employee, entrepreneur or civil servant (compared to farmers), being unmarried, and residing in a suburb (compared to a city) were associated with higher WTP. Conclusions: Although the proportion of the participants who would accept the Ebola vaccine was relatively high, the amount they were willing to pay for Ebola vaccine was very low. This finding would indicate the need of subsidies for Ebola vaccine in the country.

Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia

“…Indonesia is a middle-income country with relatively low vaccine coverage and high vaccine hesitancy (18)(19)(20). Some studies have been conducted to assess acceptance on new vaccines against emerging and re-emerging infectious diseases in southeast Asia, such as for dengue (21)(22)(23)(24)(25), Zika (26), and Ebola (27). No study has been conducted on COVID-19 vaccine acceptance in the region.…”

On Imported and Domestic Human Papillomavirus Vaccines: Cognition, Attitude, and Willingness to Pay in Chinese Medical Students

“…This hinders the coverage of HPV vaccines to a certain extent. The main problems encountered in the promotion of any new vaccine, especially those that require payment, are the public's response and the attitudes of different groups toward the purchase of vaccines ( 7 , 8 ). Particularly in developing countries, high prices have always been a major obstacle to the introduction of HPV vaccines.…”

The global prevalence and association between the risk of myocarditis and mRNA-based COVID-19 vaccination: A network meta-analysis

“…On the other hand, the knowledge of patients on the side effect of mRNA COVID-19 vaccination should be investigated to assess the willingness for COVID-19 vaccination. [48][49][50][51] Our study had several important limitations. First, the potential confounding factors that might contribute to the development of myocarditis (e.g., infection due to common causative agents such as Coxsackie virus, group A streptococci, chlamydia, or Trypanosoma cruzi) were not included in the analysis.…”